93 related articles for article (PubMed ID: 28536081)
1. Structural annotation of Beta-1,4-N-acetyl galactosaminyltransferase 1 (B4GALNT1) causing Hereditary Spastic Paraplegia 26.
Dad R; Malik U; Javed A; Minassian BA; Hassan MJ
Gene; 2017 Aug; 626():258-263. PubMed ID: 28536081
[TBL] [Abstract][Full Text] [Related]
2. Loss of Enzyme Activity in Mutated B4GALNT1 Gene Products in Patients with Hereditary Spastic Paraplegia Results in Relatively Mild Neurological Disorders: Similarity with Phenotypes of B4galnt1 Knockout Mice.
Bhuiyan RH; Ohmi Y; Ohkawa Y; Zhang P; Takano M; Hashimoto N; Okajima T; Furukawa K; Furukawa K
Neuroscience; 2019 Jan; 397():94-106. PubMed ID: 30521973
[TBL] [Abstract][Full Text] [Related]
3. Aminoglycosides are efficient reagents to induce readthrough of premature termination codon in mutant B4GALNT1 genes found in families of hereditary spastic paraplegia.
Yesmin F; Bhuiyan RH; Ohmi Y; Ohkawa Y; Tajima O; Okajima T; Furukawa K; Furukawa K
J Biochem; 2020 Aug; 168(2):103-112. PubMed ID: 32282910
[TBL] [Abstract][Full Text] [Related]
4. Novel B4GALNT1 mutations in a complicated form of hereditary spastic paraplegia.
Wakil SM; Monies DM; Ramzan K; Hagos S; Bastaki L; Meyer BF; Bohlega S
Clin Genet; 2014 Nov; 86(5):500-1. PubMed ID: 24283893
[No Abstract] [Full Text] [Related]
5. Diseases of ganglioside biosynthesis: An expanding group of congenital disorders of glycosylation.
Trinchera M; Parini R; Indellicato R; Domenighini R; dall'Olio F
Mol Genet Metab; 2018 Aug; 124(4):230-237. PubMed ID: 29983310
[TBL] [Abstract][Full Text] [Related]
6. Homozygous B4GALNT1 mutation and biochemical glutaric acidemia type II: A case report.
Rose L; Hall K; Tang S; Hasadsri L; Kimonis V
Clin Neurol Neurosurg; 2020 Feb; 189():105553. PubMed ID: 31812852
[No Abstract] [Full Text] [Related]
7. Functional validation of novel variants in B4GALNT1 associated with early-onset complex hereditary spastic paraplegia with impaired ganglioside synthesis.
Alecu JE; Ohmi Y; Bhuiyan RH; Inamori KI; Nitta T; Saffari A; Jumo H; Ziegler M; de Gusmao CM; Sharma N; Ohno S; Manabe N; Yamaguchi Y; Kambe M; Furukawa K; Sahin M; Inokuchi JI; Furakawa K; Ebrahimi-Fakhari D
Am J Med Genet A; 2022 Sep; 188(9):2590-2598. PubMed ID: 35775650
[TBL] [Abstract][Full Text] [Related]
8. B4GALNT1 induces angiogenesis, anchorage independence growth and motility, and promotes tumorigenesis in melanoma by induction of ganglioside GM2/GD2.
Yoshida H; Koodie L; Jacobsen K; Hanzawa K; Miyamoto Y; Yamamoto M
Sci Rep; 2020 Jan; 10(1):1199. PubMed ID: 31988291
[TBL] [Abstract][Full Text] [Related]
9. Mutations in B4GALNT1 (GM2 synthase) underlie a new disorder of ganglioside biosynthesis.
Harlalka GV; Lehman A; Chioza B; Baple EL; Maroofian R; Cross H; Sreekantan-Nair A; Priestman DA; Al-Turki S; McEntagart ME; Proukakis C; Royle L; Kozak RP; Bastaki L; Patton M; Wagner K; Coblentz R; Price J; Mezei M; Schlade-Bartusiak K; Platt FM; Hurles ME; Crosby AH
Brain; 2013 Dec; 136(Pt 12):3618-24. PubMed ID: 24103911
[TBL] [Abstract][Full Text] [Related]
10. B4GALNT1 promotes progression and metastasis in lung adenocarcinoma through JNK/c-Jun/Slug pathway.
Jiang T; Wu H; Lin M; Yin J; Tan L; Ruan Y; Feng M
Carcinogenesis; 2021 Apr; 42(4):621-630. PubMed ID: 33367717
[TBL] [Abstract][Full Text] [Related]
11. A novel mutation in PLP1 causes severe hereditary spastic paraplegia type 2.
Noetzli L; Sanz PG; Brodsky GL; Hinckley JD; Giugni JC; Giannaula RJ; Gonzalez-Alegre P; Di Paola J
Gene; 2014 Jan; 533(1):447-50. PubMed ID: 24103481
[TBL] [Abstract][Full Text] [Related]
12. Novel De Novo Mutations in KIF1A as a Cause of Hereditary Spastic Paraplegia With Progressive Central Nervous System Involvement.
Hotchkiss L; Donkervoort S; Leach ME; Mohassel P; Bharucha-Goebel DX; Bradley N; Nguyen D; Hu Y; Gurgel-Giannetti J; Bönnemann CG
J Child Neurol; 2016 Aug; 31(9):1114-9. PubMed ID: 27034427
[TBL] [Abstract][Full Text] [Related]
13. Loss-of-function mutations in the ATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78).
Estrada-Cuzcano A; Martin S; Chamova T; Synofzik M; Timmann D; Holemans T; Andreeva A; Reichbauer J; De Rycke R; Chang DI; van Veen S; Samuel J; Schöls L; Pöppel T; Mollerup Sørensen D; Asselbergh B; Klein C; Zuchner S; Jordanova A; Vangheluwe P; Tournev I; Schüle R
Brain; 2017 Feb; 140(2):287-305. PubMed ID: 28137957
[TBL] [Abstract][Full Text] [Related]
14. Hereditary spastic paraplegia: identification of an SPG3A gene mutation in a Chinese family.
Chan KY; Ching CK; Mak CM; Lam CW; Chan AY
Hong Kong Med J; 2009 Aug; 15(4):304-7. PubMed ID: 19652243
[TBL] [Abstract][Full Text] [Related]
15. Dominant transmission of de novo KIF1A motor domain variant underlying pure spastic paraplegia.
Ylikallio E; Kim D; Isohanni P; Auranen M; Kim E; Lönnqvist T; Tyynismaa H
Eur J Hum Genet; 2015 Oct; 23(10):1427-30. PubMed ID: 25585697
[TBL] [Abstract][Full Text] [Related]
16. Mutation in KIF5A can also cause adult-onset hereditary spastic paraplegia.
Blair MA; Ma S; Hedera P
Neurogenetics; 2006 Mar; 7(1):47-50. PubMed ID: 16489470
[TBL] [Abstract][Full Text] [Related]
17. CYP2U1 activity is altered by missense mutations in hereditary spastic paraplegia 56.
Durand CM; Dhers L; Tesson C; Tessa A; Fouillen L; Jacqueré S; Raymond L; Coupry I; Benard G; Darios F; El-Hachimi KH; Astrea G; Rivier F; Banneau G; Pujol C; Lacombe D; Durr A; Babin PJ; Santorelli FM; Pietrancosta N; Boucher JL; Mansuy D; Stevanin G; Goizet C
Hum Mutat; 2018 Jan; 39(1):140-151. PubMed ID: 29034544
[TBL] [Abstract][Full Text] [Related]
18. A missense mutation in the coiled-coil domain of the KIF5A gene and late-onset hereditary spastic paraplegia.
Lo Giudice M; Neri M; Falco M; Sturnio M; Calzolari E; Di Benedetto D; Fichera M
Arch Neurol; 2006 Feb; 63(2):284-7. PubMed ID: 16476820
[TBL] [Abstract][Full Text] [Related]
19. Prenatal diagnosis of autosomal dominant hereditary spastic paraplegia (SPG42) caused by SLC33A1 mutation in a Chinese kindred.
Lin P; Mao F; Liu Q; Shao C; Yan C; Gong Y
Prenat Diagn; 2010 May; 30(5):485-6. PubMed ID: 20306460
[No Abstract] [Full Text] [Related]
20. ZFYVE26/SPASTIZIN and SPG11/SPATACSIN mutations in hereditary spastic paraplegia types AR-SPG15 and AR-SPG11 have different effects on autophagy and endocytosis.
Vantaggiato C; Panzeri E; Castelli M; Citterio A; Arnoldi A; Santorelli FM; Liguori R; Scarlato M; Musumeci O; Toscano A; Clementi E; Bassi MT
Autophagy; 2019 Jan; 15(1):34-57. PubMed ID: 30081747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
